TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year May 23, 1975
TCL Archive Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws November 20, 1992
